Canada markets open in 8 hours 41 minutes

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
74.19-0.70 (-0.93%)
At close: 04:00PM EDT
75.00 +0.81 (+1.09%)
After hours: 05:31PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.52B
Enterprise Value 3.32B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.45
Price/Book (mrq)18.44
Enterprise Value/Revenue 12.28
Enterprise Value/EBITDA -14.77

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 31.56%
S&P500 52-Week Change 321.33%
52 Week High 398.40
52 Week Low 355.02
50-Day Moving Average 374.66
200-Day Moving Average 374.79

Share Statistics

Avg Vol (3 month) 3726.01k
Avg Vol (10 day) 3559.4k
Shares Outstanding 547.49M
Implied Shares Outstanding 647.49M
Float 834.91M
% Held by Insiders 117.04%
% Held by Institutions 183.57%
Shares Short (Apr 15, 2024) 47.75M
Short Ratio (Apr 15, 2024) 411.26
Short % of Float (Apr 15, 2024) 419.69%
Short % of Shares Outstanding (Apr 15, 2024) 416.36%
Shares Short (prior month Mar 15, 2024) 47.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -88.41%
Operating Margin (ttm)-77.68%

Management Effectiveness

Return on Assets (ttm)-24.86%
Return on Equity (ttm)-159.21%

Income Statement

Revenue (ttm)270.6M
Revenue Per Share (ttm)5.96
Quarterly Revenue Growth (yoy)193.50%
Gross Profit (ttm)N/A
EBITDA -182.45M
Net Income Avi to Common (ttm)-239.24M
Diluted EPS (ttm)-5.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)386.19M
Total Cash Per Share (mrq)8.15
Total Debt (mrq)186.37M
Total Debt/Equity (mrq)97.59%
Current Ratio (mrq)3.63
Book Value Per Share (mrq)4.03

Cash Flow Statement

Operating Cash Flow (ttm)-145.08M
Levered Free Cash Flow (ttm)-78.72M